Evidence map›Paper›PMID 36851365›Full record

ArticleVaccines2023

Acceptance, Advocacy, and Perception of Health Care Providers on COVID-19 Vaccine: Comparing Early Stage of COVID-19 Vaccination with Latter Stage in the Eastern Region of Saudi Arabia.

Eman M Almusalami, Mohammed I Al-Bazroun, Amal I Alhasawi, Fatimah S Alahmed, Zahra M Al-Muslim, Lubana I Al-Bazroun, Maryam Muslim, Chandni Saha, Elbert Kay, Zeyad A Alzahrani and 2 more

Abstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Temporal trends in vaccine hesitancy among Caribbean health workers: analysis of 2021 and 2024 surveys.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eman M AlmusalamiResearch Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.
Mohammed I Al-BazrounQatif Health Network, Qatif 32654, Saudi Arabia.ORCID 0000-0003-3553-6182
Amal I AlhasawiQatif Health Network, Qatif 32654, Saudi Arabia.
Fatimah S AlahmedQatif Health Network, Qatif 32654, Saudi Arabia.
Zahra M Al-MuslimQatif Health Network, Qatif 32654, Saudi Arabia.
Lubana I Al-BazrounDhahran Eye Specialist Hospital, Dhahran 34257, Saudi Arabia.
Maryam MuslimAlmoosa College of Health Sciences, Al-Ahsa 36342, Saudi Arabia.ORCID 0000-0003-0929-081X
Chandni SahaResearch Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.
Elbert KayPopulation Health Department, John Hopkins Aramco Healthcare, Al-khober 31952, Saudi Arabia.
Zeyad A AlzahraniAdministration, Presidency of State Security Hospital, Riyadh 12223, Saudi Arabia.
Gasmelseed Y AhmedColumbia University Hospital, New York, NY 10027-6907, USA.ORCID 0000-0003-0267-1687
Abbas Al MutairResearch Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination of healthcare providers has recently gained focused attention of public health officials. As HCPs have direct contact with the population, and HCPs significantly influence the population, this study aimed to compare the acceptance rate, advocacy rate, and beliefs about the COVID-19 vaccine among HCPs in two time periods. In this repeated cross-sectional study, different HCPs were assessed in two periods ten months apart, i.e., November to December 2020 and September to October 2021, which were before and after COVID-19 vaccine approval by authorities. The study was conducted in Qatif Central Hospital, Eastern Region of Saudi Arabia. There were 609 respondents: 236 participants in the first period and 373 participants in the second period. Only 13 participants did not get the COVID-19 vaccine. There was around a 40% difference in the acceptance rate between the two study periods; the latter period was higher at 94.7%. Furthermore, 24.1% was the difference between the willingness to advocate the COVID-19 vaccine for others; the first period had a lower percentage (60.1%). Overall, results of the study showed that vaccine hesitancy, as well as the willingness to advocate for the vaccine, were improved between the pre-vaccine approval period and post-vaccine approval period, showing that the efforts made by the government improved COVID-19 acceptance and advocacy among HCPs. However, vaccine hesitancy is not a new issue, and for a better understanding of HCPs' beliefs, a qualitative study is needed.

Indexed as

acceptanceadvocacyCOVID-19HCPsvaccine

Identifiers

PMID36851365
PMCPMC9963779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.